Express News | PTC Therapeutics Shares Are Trading Higher After Morgan Stanley Upgraded the Stock From Underweight to Equal-Weight and Raised Its Price Target From $28 to $30
Benzinga3minutes ago
NYSE American New 52-Week Highs And Lows
New Highs 7 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Air Industries Group AIRI 7.24 71,596 Ar
Dow Jones7minutes ago
Market Clubhouse Morning Memo - April 29th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, And TSLA)
Good Morning Traders! In today's Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. Our proprietary formula, exclusive to Market Clubhouse, dictates thes
Benzinga12minutes ago
Form 8.3 - Hipgnosis Songs Fund Limited
Yahoo Finance13minutes ago
Express News | Annovis Bio Inc - Buntanetap Is Safe and Well Tolerated
Reuters15minutes ago
Express News | Annovis Bio Inc - Efficacy in Cgic Endpoint Was Not Reached Due to Limited Number of Patients and Short Trial Duration
Reuters15minutes ago
Express News | Annovis Bio Inc: Improvement in Cognition Measured by Adas-Cog 11 at Three Months Is 3.3 Points as Compared to 0.3 for Placebo in Study
Reuters16minutes ago
Express News | Annovis Bio Inc: Annovis Plans to Conduct a Pivotal Disease-Modifying Phase III Trial in Biomarker-Positive Early Ad Patients
Reuters16minutes ago
Express News | Annovis Bio Inc: Plasma Tau Protein Levels Are Reduced in Study Consistent With Our Previous Phase II Biomarker Data
Reuters16minutes ago
Express News | Annovis Bio Inc: Adas-Cog 11 (Co-Primary Endpoint) Shows a 3.3 Statistically Significant Improvement
Reuters16minutes ago
Express News | Annovis Bio Inc: Significantly Higher Rate of Improvement in Adas-Cog 11 Scores in Each Treatment Dose Relative to Placebo for Patients With Mild Ad
Reuters17minutes ago
Express News | Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
Reuters17minutes ago
Exponent Is Maintained at Buy by Truist Securities
Exponent Is Maintained at Buy by Truist Securities
Dow Jones24minutes ago
ImmunityBio, Aquestive Therapeutics, Clever Leaves Holdings Among Healthcare Movers
Seeking Alpha24minutes ago
Defense Metals Receives Positive Results From Ucore Rare Metals Inc. on Its Wicheeda Rare Earth Carbonate Sample
Yahoo Finance27minutes ago
Exponent Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/29/2024 7.37% Truist Securities $95 → $100 Maintains Buy 02/02/2024 2% Truist Securities $110 → $95 Mai
Benzinga35minutes ago
Microsoft Tops Estimates Across Its Business But Signals Near-Term Capacity Challenges
On Thursday, Microsoft Corporation (NASDAQ:MSFT) issued its third quarter earnings report. Year to date, Microsoft shares are 10% up, behind its tech rivals, Google parent Alphabet (NASDAQ:GOOG)(NASDA
Benzinga36minutes ago
Express News | Annovis Bio Shares Halted, News Pending
Benzinga37minutes ago
Express News | NYSE Halt Annovis Bio Ord News Pending Lst $15.000000
Reuters38minutes ago
Apple's iPad OS Among 22 Services Labeled 'Gatekeepers' By European Commission
Apple Inc.'s (NASDAQ:AAPL) iPad operating system, iPadOS, has been labeled as a gatekeeper by the European Union's antitrust regulators, according to the European Commission's recent announcement.What
Benzinga42minutes ago